Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest National Cancer Institute Stories

2013-12-13 09:37:18

A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute (NCI), may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and...

2013-12-09 23:21:19

Results from an ECOG-ACRIN Cancer Research Group trial show the benefit of using the combination of docetaxel and ADT as initial treatment. Philadelphia, PA (PRWEB) December 09, 2013 Men suffering from highly advanced prostate cancer have new hope for longer survival times based on a recent clinical trial, the interim results of which were just announced by the National Institutes of Health. The findings suggest that physicians can immediately consider changing their clinical practice...

2013-12-07 16:20:24

- Findings Presented at 55th American Society of Hematology (ASH) Annual Meeting - LOS ANGELES, Dec. 7, 2013 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on engineered autologous T cell therapy (eACT) products for cancer, today announced positive clinical data demonstrating that Kite's most advanced product candidate can produce robust and durable tumor shrinkage in patients with an aggressive form of non-Hodgkin's lymphoma. In an oral...

2013-12-03 23:25:07

The Meso Foundation congratulates Congresswomen Betty McCollum and Chellie Pingree for sending a letter to all members of the U.S. House of Representatives requesting they sign on to urge the National Cancer Institute to further mesothelioma research. Alexandria, VA (PRWEB) December 03, 2013 Yesterday, U.S. Congresswomen Betty McCollum (D-MN) and Chellie Pingree (D-ME) sent a “Dear Colleague” letter to all members of the U.S. House of Representatives asking them to join them in urging...

2013-12-02 08:31:38

WASHINGTON, Dec. 2, 2013 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) hailed action by members of the U.S. Senate to raise the research profile of gastric cancer research. The action, which took place during Curing Stomach Cancer Month, was in the form of a bipartisan letter to National Cancer Institute (NCI) Director Harold Varmus, M.D., led by Sen. Mark Kirk (R-IL) and signed by Sens. Sherrod Brown (D-OH), Robert Menendez (D-NJ), Marco Rubio (R-FL), and...

2013-11-22 16:26:36

By the National Cancer Institute BETHESDA, Md., Nov. 22, 2013 /PRNewswire-USNewswire/ -- Editor's Note: The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets. (Logo: http://photos.prnewswire.com/prnh/20111018/DC89117LOGO) November is Lung Cancer Awareness Month. Lung cancer has been the leading cause of cancer deaths among African American men for...

2013-11-19 11:57:42

Vitamin B12 (cobalamin [Cbl]) is essential for maintaining healthy bodily function but higher than normal levels (reference range 200-600 pmol/L) may indicate that a patient is at risk of developing certain cancers, according to a study published November 18 in the Journal of the National Cancer Institute. Previous studies had suggested an association between high Cbl levels and specific cancers. To assess the association between high Cbl levels and risk of cancer of any type, Johan...

2013-11-14 11:32:11

Adult patients with a type of cancer known as Burkitt lymphoma had excellent long-term survival rates—upwards of 90 percent—following treatment with low-intensity chemotherapy regimens, according to a new clinical trial finding. Standard treatment for Burkitt lymphoma involves high-dose chemotherapy, which has a high rate of toxicity, including death, and cures only 60 percent of adult patients. This trial was conducted by researchers at the National Cancer Institute (NCI), part of the...

2013-11-11 08:28:02

Competition to develop more efficient treatment strategies for breast cancer patients awards six leading teams cash prizes MARINA DEL REY, Calif., Nov. 11, 2013 /PRNewswire/ -- Heritage Provider Network, (HPN) The National Cancer Institute, (NCI) Sage Bionetworks and DREAM announced the best performers in the Heritage-DREAM Breast Cancer Network Inference Challenge. The competition challenged teams to use big data to develop more effective treatments for breast cancer. Six best...

2013-11-07 12:28:51

CHARLOTTESVILLE, Va., Nov. 7, 2013 /PRNewswire/ -- Safer and more effective anticancer drugs may soon be developed thanks to a Small Business Innovation Research contract recently awarded to HemoShear by the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH). HemoShear, LLC, is the pharmaceutical industry's leading developer of the most advanced human biology systems for applications in drug research and development. (Logo:...